BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6182049)

  • 1. [Recent findings in the field of oncological therapy with interferon].
    Pugliese A; Vitale M; Cosseta P
    G Batteriol Virol Immunol; 1981; 74(7-12):308-19. PubMed ID: 6182049
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological and therapeutical experience with human interferon-beta in malignant tumors in children.
    Niethammer D; Treuner J
    Tex Rep Biol Med; 1981-1982; 41():641-6. PubMed ID: 6763371
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferons and cancer therapy.
    Priestman TJ
    J Pathol; 1983 Nov; 141(3):287-95. PubMed ID: 6363649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antineoplastic effect of interferon].
    Olesen BK; Ernst P
    Ugeskr Laeger; 1986 Feb; 148(7):375-7. PubMed ID: 2420053
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of condyloma acuminatum with interferon.
    Tyring SK
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):35-40. PubMed ID: 2461596
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferons and cancer: what is the present position?
    Priestman TJ
    Radiography; 1983 Jan; 49(577):17-9. PubMed ID: 6191356
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical application of fibroblast interferon--an overview.
    Billiau A
    Med Oncol Tumor Pharmacother; 1984; 1(2):87-96. PubMed ID: 6400034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferons and cancer: how the promise is being kept.
    Borden EC
    Interferon; 1983; 5():43-83. PubMed ID: 6202643
    [No Abstract]   [Full Text] [Related]  

  • 9. Nasopharyngeal ca treated with interferon.
    J Pak Med Assoc; 1981 Jan; 31(1):28-9. PubMed ID: 6162973
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferons: not just alpha.
    Krown SE
    Cancer Treat Rep; 1986 Dec; 70(12):1353-5. PubMed ID: 2431773
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon: a model for future biologicals.
    Oldham RK
    Interferon; 1985; 6():127-43. PubMed ID: 2410369
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interferon: validity, risks, prospects of clinical use].
    Rossi GB; Belardelli F
    Epidemiol Prev; 1987 Mar; 9(30):13-5. PubMed ID: 2466676
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials with interferon in Japan.
    Imanishi J; Kishida T
    Tex Rep Biol Med; 1981-1982; 41():647-52. PubMed ID: 6189229
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical investigation of partially pure and recombinant DNA derived leukocyte interferon in human cancer.
    Gutterman J; Quesada J
    Tex Rep Biol Med; 1981-1982; 41():626-33. PubMed ID: 6763369
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon: anticancer agent having multifarious activity.
    Yabrov AA
    Prog Clin Cancer; 1982; 8():99-145. PubMed ID: 6185970
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies with interferon-alpha in human tumors.
    Einhorn S; Strander H
    Med Oncol Tumor Pharmacother; 1984; 1(2):97-9. PubMed ID: 6400035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of interferon and its possible use as an antineoplastic agent.
    Strander H
    Tex Rep Biol Med; 1981-1982; 41():621-5. PubMed ID: 6763368
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon-alpha: current status and future promise.
    Bonnem EM; Spiegel RJ
    J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interferon in the treatment of recurrent laryngeal papillomas].
    Lenarcić-Cepelja I; Krajina Z
    Laryngol Rhinol Otol (Stuttg); 1984 Aug; 63(8):401-2. PubMed ID: 6482620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of nasopharyngeal cancer with interferon].
    Treuner J; Niethammer D
    Strahlentherapie Sonderb; 1984; 78():184-7. PubMed ID: 6203189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.